112 related articles for article (PubMed ID: 16949120)
1. Cell-mediated immune responses to COPV early proteins.
Jain S; Moore RA; Anderson DM; Gough GW; Stanley MA
Virology; 2006 Dec 5-20; 356(1-2):23-34. PubMed ID: 16949120
[TBL] [Abstract][Full Text] [Related]
2. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes.
Johnston KB; Monteiro JM; Schultz LD; Chen L; Wang F; Ausensi VA; Dell EC; Santos EB; Moore RA; Palker TJ; Stanley MA; Jansen KU
Virology; 2005 Jun; 336(2):208-18. PubMed ID: 15892962
[TBL] [Abstract][Full Text] [Related]
3. Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles.
Moore RA; Santos EB; Nicholls PK; White KL; Anderson DM; Lloyd A; Topley P; Romanos M; Thomsen L; Parmar V; Walcott S; Gough GW; Stanley MA
Virology; 2002 Dec; 304(2):451-9. PubMed ID: 12504584
[TBL] [Abstract][Full Text] [Related]
4. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
[TBL] [Abstract][Full Text] [Related]
6. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes.
Nicholls PK; Moore PF; Anderson DM; Moore RA; Parry NR; Gough GW; Stanley MA
Virology; 2001 Apr; 283(1):31-9. PubMed ID: 11312659
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic immunisation with COPV early genes by epithelial DNA delivery.
Moore RA; Walcott S; White KL; Anderson DM; Jain S; Lloyd A; Topley P; Thomsen L; Gough GW; Stanley MA
Virology; 2003 Sep; 314(2):630-5. PubMed ID: 14554090
[TBL] [Abstract][Full Text] [Related]
8. Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination.
Moore RA; Nicholls PK; Santos EB; Gough GW; Stanley MA
J Gen Virol; 2002 Sep; 83(Pt 9):2299-2301. PubMed ID: 12185285
[TBL] [Abstract][Full Text] [Related]
9. Detection of canine oral papillomavirus DNA in conjunctival epithelial hyperplastic lesions of three dogs.
Brandes K; Fritsche J; Mueller N; Koerschgen B; Dierig B; Strebelow G; Teifke JP
Vet Pathol; 2009 Jan; 46(1):34-8. PubMed ID: 19112112
[TBL] [Abstract][Full Text] [Related]
10. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
Suzich JA; Ghim SJ; Palmer-Hill FJ; White WI; Tamura JK; Bell JA; Newsome JA; Jenson AB; Schlegel R
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11553-7. PubMed ID: 8524802
[TBL] [Abstract][Full Text] [Related]
11. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
12. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
13. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.
Stanley MA; Moore RA; Nicholls PK; Santos EB; Thomsen L; Parry N; Walcott S; Gough G
Vaccine; 2001 Apr; 19(20-22):2783-92. PubMed ID: 11282188
[TBL] [Abstract][Full Text] [Related]
14. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
15. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression.
Kang Y; Jin H; Zheng G; Du X; Xiao C; Zhang X; Geng S; Li X; Wang J; Chen A; Wang B
Biochem Biophys Res Commun; 2007 Feb; 353(4):1034-9. PubMed ID: 17204242
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
18. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.
Niesalla H; de Andrés X; Barbezange C; Fraisier C; Reina R; Arnarson H; Biescas E; Mazzei M; McNeilly TN; Liu C; Watkins C; Perez M; Carrozza ML; Bandecchi P; Solano C; Crespo H; Glaria I; Huard C; Shaw DJ; de Blas I; de Andrés D; Tolari F; Rosati S; Suzan-Monti M; Andrésdottir V; Torsteinsdottir S; Petursson G; Badiola J; Lujan L; Pepin M; Amorena B; Blacklaws B; Harkiss GD
Vaccine; 2009 Jan; 27(2):260-9. PubMed ID: 18984025
[TBL] [Abstract][Full Text] [Related]
19. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
20. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
